Overall, no significant association between the ATM rs664677 polymorphism and cancer risk was observed in any genetic model (heterozygote comparison: OR = 1.018, 95% CI = 0.791–1.311; dominant model comparison: OR = 1.026, 95% CI = 0.812–1.295). The gene discussed is ATM; the disease is cancer.